|
Geezeo Takes a Walk on The Sunny Side of TheStreet.com
|
Wade Roush |
04/24/08 |
|
1 Comment
|
|
Dynogen, Apex Call Off Reverse Merger
|
Rebecca Zacks |
04/17/08 |
|
No Comments
|
|
Monotype Files for SPO
|
Rebecca Zacks |
04/02/08 |
|
No Comments
|
|
RXi’s Debut, Sirtris’ Surprising Deal, Hydra’s Big Financing Round, & More of the Last Week in Life Sciences
|
Rebecca Zacks |
03/19/08 |
|
No Comments
|
|
Diomed Files for Bankruptcy, Plans Sale
|
Rebecca Zacks |
03/14/08 |
|
No Comments
|
|
Mello RNAi Firm RXi Pharmaceuticals Has Wild Ride on First Day of Trading
|
Rebecca Zacks |
03/12/08 |
|
No Comments
|
|
Curis, Alkermes Down on News of Failed Pharma Partnerships
|
Rebecca Zacks |
03/10/08 |
|
No Comments
|
|
AspenTech Delisted from NASDAQ
|
Rebecca Zacks |
02/15/08 |
|
No Comments
|
|
With a Whole Lot of Spending to Do, Vertex Seeks Some $400 Million in Stock and Note Offerings
|
Rebecca Zacks |
02/13/08 |
|
No Comments
|
|
Evergreen Solar Plans Offering, ThingMagic Teams With Ford, Dynogen Reverse-Merges Onto the Market, & More
|
Rebecca Zacks |
02/12/08 |
|
No Comments
|
|
Targanta Files for FDA Approval of Anti-MRSA Drug
|
Rebecca Zacks |
02/11/08 |
|
No Comments
|
|
Dynogen Goes Public Via Reverse Merger
|
Rebecca Zacks |
02/06/08 |
|
No Comments
|
|
Evergreen Solar Plans $230M Secondary Offering
|
Rebecca Zacks |
02/04/08 |
|
1 Comment
|
|
Elixir Postpones IPO
|
Rebecca Zacks |
01/17/08 |
|
No Comments
|
|
Elixir, NameMedia, Archemix, and More: What’s on Tap for New England IPOs in 2008
|
Rebecca Zacks |
01/11/08 |
|
No Comments
|
|
Vertex Falls On Hepatitis Drug Delay Reports
|
Robert Buderi |
01/04/08 |
|
No Comments
|
|
Glasshouse Plots for VMware IPO Sequel, Idera Partners With Merck, iRobot Inks Deal With Army, & More
|
Rebecca Zacks |
12/24/07 |
|
1 Comment
|
|
Elixir Sets Price Target for IPO
|
Robert Buderi |
12/19/07 |
|
No Comments
|
|
Nuance Cuts Stock Offering Size
|
Robert Buderi |
12/19/07 |
|
No Comments
|
|
Harvard Bioscience to Buy Back $10M in Stock
|
Rebecca Zacks |
12/07/07 |
|
No Comments
|
|
Inverness Nets $806.4M in Stock Sale
|
Malorye Allison |
11/21/07 |
|
No Comments
|
|
Inverness Prices Secondary Public Offering, Nearly Doubling Its Size
|
Rebecca Zacks |
11/15/07 |
|
No Comments
|
|
Verenium Files $150 Million Shelf Registration
|
Rebecca Zacks |
11/15/07 |
|
No Comments
|
|
Insulet Prices SPO
|
Rebecca Zacks |
11/07/07 |
|
No Comments
|
|
Genzyme CEO Nets $9.3 Million From Options
|
Rebecca Zacks |
10/31/07 |
|
No Comments
|
|
EnerNOC Plans Secondary Offering
|
Rebecca Zacks |
10/29/07 |
|
No Comments
|
|
Big Gains for Akamai, EMC, Monster, VMware
|
Wade Roush |
10/25/07 |
|
No Comments
|
|
Insulet Files for Secondary Offering
|
Rebecca Zacks |
10/20/07 |
|
No Comments
|
|
Market Likes Millennium’s Velcade News; Analysts Not So Sure
|
Rebecca Zacks |
09/18/07 |
|
No Comments
|
|
VMware Snaps Up Swiss Software Suite, Sees Stock Swell
|
Wade Roush |
09/11/07 |
|
No Comments
|
